Celcuity logo
Celcuity
CELC | NASDAQ
Chart Builder DCF Calculator
$60.57
-$3.80 (-5.90%)
At close: Nov 16, 2026, 4:00 PM ET
$60.57
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:41 PM ET

Celcuity Company Profile

Company profile explained

Company Profile

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Key Executives

Name Position
Brian F. Sullivan Co-Founder, Chairman & Chief Executive Officer
Vicky Hahne Chief Financial Officer
Brent Eilefson General Counsel & Chief Compliance Officer
Byron Robinson Chief Strategy Officer
Eldon C. Mayer Chief Commercial Officer
Igor Gorbatchevsky Chief Medical Officer
Jodi Sievers Head of Investor Relations & Corporate Communications
Lance G. Laing Co-Founder, Chief Science Officer, Vice President, Secretary & Director
Sheri Smith Acting Head of Clinical Operations

Latest SEC Filings

Date Type Title
Oct 09, 2026 4 Filing
Oct 05, 2026 4 Filing
Oct 05, 2026 3 Filing
Oct 02, 2026 8-K Current Report
Sep 30, 2026 8-K Current Report
Aug 26, 2026 8-K Current Report
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 13, 2026 10-Q Quarterly Report
View All SEC Filings ➞
Celcuity
Celcuity logo
Country United States
IPO Date Sep 19, 2017
Industry Biotechnology
Sector Healthcare
Employees 155
CEO Brian F. Sullivan

Contact Details

2800 Campus Drive Minneapolis, Minnesota 55441 United States

Stock Details

Ticker Symbol CELC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001603454
CUSIP Number 15102K100
ISIN Number US15102K1007
SIC Code 8071

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.